Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meejeon Roh

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMC Cancer|June 3, 2010
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activityJongchan Kim, Meejeon Roh, Sarki A Abdulkadir
Journal of Cellular Physiology|April 20, 2011
Tumorigenic polyploid cells contain elevated ROS and ARE selectively targeted by antioxidant treatmentMeejeon Roh, Riet van der Meer, Sarki A Abdulkadir
The Journal of Biological Chemistry|October 14, 2005
Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1Meejeon Roh, Chisu Song, Jongchan Kim, et al.
Genesis (New York, N.Y. : 2000)|October 3, 2006
Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissuesMeejeon Roh, Jongchan Kim, Chisu Song, et al.
Current Opinion in Pharmacology|August 11, 2020
Targeting CD73 to augment cancer immunotherapyMeejeon Roh, Derek A Wainwright, Jennifer D Wu, et al.
Plos Genetics|July 7, 2009
Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancerJongchan Kim, Isam-Eldin A Eltoum, Meejeon Roh, et al.
Biochimica Et Biophysica Acta|April 22, 2005
Proteolytic processing of TGFalpha redirects its mitogenic activity: the membrane-anchored form is autocrine, the secreted form is paracrineMeejeon Roh, Andrew J Paterson, Kan Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibitionRiet van der Meer, Ha Yong Song, Seong-Hoon Park, et al.
Plos One|July 4, 2008
A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cellsMeejeon Roh, Omar E Franco, Simon W Hayward, et al.
Oncotarget|September 9, 2017
Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoidsKenji Unno, Meejeon Roh, Young A Yoo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMC Cancer|June 3, 2010
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activityJongchan Kim, Meejeon Roh, Sarki A Abdulkadir
Journal of Cellular Physiology|April 20, 2011
Tumorigenic polyploid cells contain elevated ROS and ARE selectively targeted by antioxidant treatmentMeejeon Roh, Riet van der Meer, Sarki A Abdulkadir
The Journal of Biological Chemistry|October 14, 2005
Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1Meejeon Roh, Chisu Song, Jongchan Kim, et al.
Genesis (New York, N.Y. : 2000)|October 3, 2006
Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissuesMeejeon Roh, Jongchan Kim, Chisu Song, et al.
Current Opinion in Pharmacology|August 11, 2020
Targeting CD73 to augment cancer immunotherapyMeejeon Roh, Derek A Wainwright, Jennifer D Wu, et al.
Plos Genetics|July 7, 2009
Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancerJongchan Kim, Isam-Eldin A Eltoum, Meejeon Roh, et al.
Biochimica Et Biophysica Acta|April 22, 2005
Proteolytic processing of TGFalpha redirects its mitogenic activity: the membrane-anchored form is autocrine, the secreted form is paracrineMeejeon Roh, Andrew J Paterson, Kan Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibitionRiet van der Meer, Ha Yong Song, Seong-Hoon Park, et al.
Plos One|July 4, 2008
A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cellsMeejeon Roh, Omar E Franco, Simon W Hayward, et al.
Oncotarget|September 9, 2017
Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoidsKenji Unno, Meejeon Roh, Young A Yoo, et al.
Pageof 2